Upper gastrointestinal Dieulafoy's lesions and endoscopic treatment: First report from a Mexican centre | Zendy

Gustavo López-Arce | Zendy; Sergio Zepeda-Gómez | Zendy; Norberto C. ChávezTapia | Zendy; Sandra García-Osogobio | Zendy; Ada M. Franco-Guzmán | Zendy; Miguel Ángel RamírezLuna | Zendy; Félix I. TéllezÁvila | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Upper gastrointestinal Dieulafoy's lesions and endoscopic treatment: First report from a Mexican centre

Author(s) -

Gustavo López-Arce,

Sergio Zepeda-Gómez,

Norberto C. ChávezTapia,

Sandra García-Osogobio,

Ada M. Franco-Guzmán,

Miguel Ángel RamírezLuna,

Félix I. TéllezÁvila

Publication year - 2008

Publication title -

therapeutic advances in gastroenterology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 51

eISSN - 1756-2848

pISSN - 1756-283X

DOI - 10.1177/1756283x08096285

Subject(s) - medicine , lesion , surgery , curvatures of the stomach , mortality rate , endoscopic treatment , open surgery , general surgery , endoscopy , gastroenterology , stomach

The aim was to evaluate the initial success, rebleeding rate, need for emergent surgery, and mortality rates of patients with Dieulafoy's lesion (DL) and endoscopic treatment (ET). Patients with DL from a tertiary center were included. We included 20 patients with follow-up of 90 (60—550) days. The lesser curvature was the most common localization. Initial success, rebleeding, and emergent surgery requirement were observed in 90%, 10%, and 15%, respectively. No objective variables were related with response to ET. In conclusion, ET is secure and useful in patients with DL and it must be considered as the first-line treatment modality.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research